Company Short-Term Debts: Arcellx, Inc. (ACLX)

Graphic logo of Arcellx Therapeutics (ACLX)

Short-term financial debts under one year demonstrate a stable credit load, with 0.01 showing the value of this parameter. Arcellx is developing innovative methods to combat hematological tumors, creating safe cellular products for partnerships with industry behemoths. Successful CAR-T therapy tests and merger prospects are driving growth. Clinical stage risks are mitigated by the robust financial support of a strategic ally.

Company Short-Term Loans and Borrowings: Arcellx Inc (ACLX) for 04/28/2023 - 05/09/2026

Arcellx Therapeutics - analytical breakdowns and key metrics (ACLX)

- price and consensus price forecast:
Stock Price Arcellx, Inc.|ACLX - Consensus Target
- market capitalization data:
Market Capitalization Arcellx, Inc.|ACLX - Total Enterprise Value
- book capitalization data:
Net Assets per Single Share Arcellx|ACLX - Accounting Value of Company|Market Cap to Net Assets Ratio arcellx.com|ACLX - Aggregate Asset Value
- debt and liquidity data:
Total Debt to Capital Arcellx|ACLX - Long-Term Debt to Equity|Short-Term Debt to Equity Arcellx|ACLX - Company Debts|Debt to Book Capitalization Ratio Arcellx, Inc.|ACLX - Long-Term Debt|Company Short-Term Debt Arcellx
Fundamental company valuation:Arcellx, Inc., ACLX
Mass-produced product of Arcellx

This indicator measures the total volume of liabilities with a maturity of up to one year, allowing for an assessment of liquidity and the issuer's ability to service current loans. By analyzing the short-term debt load at the level of 0.01, an investor can determine the financial stability of Arcellx (ACLX) during a period of costly development prior to entering the high-profit scaling phase of cell therapy.

Competitor analysis for Arcellx

TGTX: Company Short-Term Debts|IRON - Company Current Liabilities|Company Short-Term Debts SNDX|KURA (Kura) - Short-Term Debt|ADCT - Company Short-Term Debt|Company Short-Term Loans and Borrowings Foghorn (FHTX)|Vor Biopharma (VOR) - Company Current Liabilities|Company Short-Term Loans and Borrowings nkartatx.com (NKTX)|Company Short-Term Debts Coeptis Therapeutics, Inc. COEP|Actinium Corp - Company Short-Term Debt|ESLA - Company Short-Term Debt|CASI: Company Short-Term Debt|Company Short-Term Debt MRKR|INAB (IN8bio Inc.) - Short-Term Debt|Company Short-Term Debt ERNA (Eterna Therapeutics, Inc.)|Short-Term Debt GT Biopharma Corporation|Company Short-Term Debts Aptose Biosciences Inc. APTO|Company Short-Term Indebtedness biopathholdings.com (BPTH)|Company Short-Term Debts MEIP (MEI Pharma)|Vincerx Pharma Inc. - Company Short-Term Debts